Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Apr 22, 2006·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Matthew C Riddle

A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes

May 30, 2006·Diabetes Care·Kjeld HermansenPhilip Home

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study

Jul 4, 2006·Lancet·Gillian L BoothJack V Tu

Incretin mimetics as a novel therapeutic option for hepatic steatosis

Sep 7, 2006·Liver International : Official Journal of the International Association for the Study of the Liver·Maarten E TushuizenRobert J Heine

A self-regulation program for maintenance of weight loss

Oct 13, 2006·The New England Journal of Medicine·Rena R WingJoseph L Fava

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Nov 14, 2006·Lancet·Daniel J Drucker, Michael A Nauck

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Dec 6, 2006·The New England Journal of Medicine·Steven E KahnADOPT Study Group

Severe iatrogenic hypoglycemia in type 2 diabetes mellitus

Dec 21, 2006·Nature Clinical Practice. Endocrinology & Metabolism·Philip E Cryer

Relation of electrocardiographic criteria for left atrial enlargement to two-dimensional echocardiographic left atrial volume measurements

Jan 2, 2007·The American Journal of Cardiology·Kwan S LeeGregory T Altemose

Initiate Insulin by Aggressive Titration and Education (INITIATE): a randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups

Mar 27, 2007·Diabetes Care·H Yki-JärvinenMarkku Vähätalo

Monogenic diabetes: implications for therapy of rare types of disease

May 10, 2007·Diabetes, Obesity & Metabolism·M T Malecki, Wojciech Mlynarski

Epidemiology and natural history of NAFLD and NASH

Jun 5, 2007·Clinics in Liver Disease·Janus P Ong, Zobair M Younossi

Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus

Jul 10, 2007·Clinical Therapeutics·Devada Singh-FrancoDavid Gazze

Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus

Jul 20, 2007·Annals of Internal Medicine·Shari BolenFrederick L Brancati

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

Sep 8, 2007·BMJ : British Medical Journal·Abd A TahraniF W F Hanna

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials

Oct 2, 2007·Lancet·Rodrigo M LagoR Nesto

The relationship between glycemic control and falls in older adults

Nov 1, 2007·Journal of the American Geriatrics Society·Joan M NelsonPaul F Cook

Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: an evidence-based comparison

Nov 27, 2007·Clinical Therapeutics·Liza L IlagMeng H Tan

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

Jan 10, 2008·Diabetes Care·John P BantleMadelyn L Wheeler

A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

Jan 22, 2008·Diabetologia·Julio RosenstockGuntram Schernthaner

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond

Jan 30, 2008·Circulation·Silvio E Inzucchi, Darren K McGuire

Acarbose: oral anti-diabetes drug with additional cardiovascular benefits

Feb 6, 2008·Expert Review of Cardiovascular Therapy·Markolf Hanefeld, Frank Schaper

Adjust to target in type 2 diabetes: comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine

Mar 28, 2008·Diabetes Care·Richard M BergenstalMarc Rendell

N of 1 trials in diabetes: making individual therapeutic decisions

Apr 5, 2008·Diabetologia·Apostolos Tsapas, David R Matthews

Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures

May 1, 2008·Diabetes Care·Russell E GlasgowSoren E Skovlund

Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?

May 16, 2008·International Journal of Clinical Practice·Serge Jabbour

Patient-important outcomes in registered diabetes trials

Jun 5, 2008·JAMA : the Journal of the American Medical Association·Gunjan Y GandhiVictor M Montori

Management of type 2 diabetes: summary of updated NICE guidance

Jun 7, 2008·BMJ : British Medical Journal·Philip HomeGuideline development group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Jun 10, 2008·The New England Journal of Medicine·Anushka PatelFlorence Travert

Effects of intensive glucose lowering in type 2 diabetes

Jun 10, 2008·The New England Journal of Medicine·Hertzel C GersteinWilliam T Friedewald

Current treatment of non-alcoholic fatty liver disease

Jun 20, 2008·Diabetes, Obesity & Metabolism·Mohamed H Ahmed, Christopher D Byrne

Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus

Jul 17, 2008·Diabetes, Obesity & Metabolism·Denis Raccah

Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes

Sep 9, 2008·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·David R Matthews, Apostolos Tsapas

10-year follow-up of intensive glucose control in type 2 diabetes

Sep 12, 2008·The New England Journal of Medicine·Rury R HolmanH Andrew W Neil

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Oct 23, 2008·Diabetologia·David M NathanEuropean Association for the Study of Diabetes

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association

Dec 19, 2008·Diabetes Care·Jay S SkylerAmerican Heart Association

The pathology of atherosclerosis: plaque development and plaque responses to medical treatment

Jan 6, 2009·The American Journal of Medicine·William Insull

GLP-1 agonist-based therapies: an emerging new class of antidiabetic drug with potential cardioprotective effects

Feb 21, 2009·Current Atherosclerosis Reports·Melanie SulistioRobert Chilton

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)

Mar 18, 2009·Diabetes Care·Bernard ZinmanLEAD-4 Study Investigators

Unraveling the science of incretin biology

Jun 2, 2009·The American Journal of Medicine·Michael A Nauck

We need minimally disruptive medicine

Aug 13, 2009·BMJ : British Medical Journal·Carl MayFrances S Mair

Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control

Sep 23, 2009·International Journal of Clinical Practice·S AkalinGlobal Task Force on Glycaemic Control

The diabetes mellitus medication choice decision aid: a randomized trial

Sep 30, 2009·Archives of Internal Medicine·Rebecca J MullanSteven Smith

Lipid receptors and islet function: therapeutic implications?

Oct 13, 2009·Diabetes, Obesity & Metabolism·M A KebedeV Poitout

Three-year efficacy of complex insulin regimens in type 2 diabetes

Oct 24, 2009·The New England Journal of Medicine·Rury R Holman4-T Study Group

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

Oct 28, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Helena W RodbardStanley S Schwartz

Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study

Dec 17, 2009·Annals of Internal Medicine·Sheldon GreenfieldSherrie H Kaplan

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

Jan 12, 2010·BMJ : British Medical Journal·Denise E BondsMary Ellen Sweeney

Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes

Jan 23, 2010·Diabetes, Obesity & Metabolism·Tina VilsbøllL Katz

Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States

Jan 30, 2010·Clinical Therapeutics·Carol E KoroSteve J Bowlin

Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know

Mar 3, 2010·The Journal of Clinical Endocrinology and Metabolism·Robert J SmithJerome I Rotter

Current antihyperglycemic treatment guidelines and algorithms for patients with type 2 diabetes mellitus

Mar 17, 2010·The American Journal of Medicine·Lawrence Blonde

Incretin-based therapies: review of current clinical trial data

Mar 17, 2010·The American Journal of Medicine·Anne L Peters

Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going

Mar 17, 2010·The American Journal of Medicine·Muhammad Abdul-Ghani

Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly

Mar 11, 2010·The Annals of Pharmacotherapy·Helen Berlie, Candice L Garwood

Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes

Mar 25, 2010·Diabetes Care·J Michael GazianoRichard E Scranton

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Mar 31, 2010·Diabetologia·Guntram SchernthanerMuhammad Abdul-Ghani

Review article: Thiazolidinediones and heart failure

Apr 7, 2010·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Parminder S ChaggarSimon G Williams

The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence

Apr 22, 2010·Diabetologia·C Nordin

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

Apr 27, 2010·Diabetes, Obesity & Metabolism·Vivian FonsecaBart Staels

Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes

Apr 27, 2010·Diabetologia·John J Nolan

The stunned beta cell: a brief history

May 7, 2010·Cell Metabolism·Ele Ferrannini

Translating comparative effectiveness into practice: the case of diabetes medications

May 18, 2010·Medical Care·Nilay D ShahVictor M Montori

Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality

Jul 27, 2010·Archives of Internal Medicine·Steven E Nissen, Kathy Wolski

The combinatorics of medications precludes evidence-based algorithms for therapy

Sep 14, 2010·Diabetologia·David Rodbard

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

Nov 3, 2010·Annals of Medicine·Giovanni MussoGianfranco Pagano

Intensified glucose control in type 2 diabetes--whose agenda?

Nov 26, 2010·Lancet·John S YudkinE A M Gale

Individuals with diabetes preferred that future trials use patient-important outcomes and provide pragmatic inferences

Nov 27, 2010·Journal of Clinical Epidemiology·Mohammad H MuradVictor M Montori

Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

Dec 1, 2010·Diabetes, Obesity & Metabolism·C F Deacon

Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues

Dec 1, 2010·Diabetes Care·Matthew C Riddle

Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes

Dec 8, 2010·Metabolism: Clinical and Experimental·Ebenezer A NyenweAbbas E Kitabchi

Standards of medical care in diabetes--2011

Jan 14, 2011·Diabetes Care·American Diabetes Association

Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications

Jan 14, 2011·The American Journal of Medicine·Michael A Nauck

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials

Jan 6, 2011·Diabetes, Obesity & Metabolism·C LamannaEdoardo Mannucci

Type 2 diabetes mellitus in 2010: individualizing treatment targets in diabetes care

Jan 26, 2011·Nature Reviews. Endocrinology·John B Buse

A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure

Feb 18, 2011·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Mayer B DavidsonPricilla Hollander

Metformin: the safest hypoglycaemic agent in chronic kidney disease?

Feb 18, 2011·Nephron. Clinical Practice·Helen J Nye, William G Herrington

Long-term effects of intensive glucose lowering on cardiovascular outcomes

Mar 4, 2011·The New England Journal of Medicine·Hertzel C GersteinWilliam T Friedewald

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Mar 16, 2011·Annals of Internal Medicine·Wendy L BennettShari Bolen

Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies

Mar 19, 2011·BMJ : British Medical Journal·Yoon Kong LokeSonal Singh

Bromocriptine: a sympatholytic, d2-dopamine agonist for the treatment of type 2 diabetes

Mar 31, 2011·Diabetes Care·Muhammad Abdul-Ghani

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study

Mar 31, 2011·Diabetes Care·James D LewisBrian L Strom

Goals of glycemic control in frail older patients with diabetes

Apr 7, 2011·JAMA : the Journal of the American Medical Association·Sei J Lee, Catherine Eng

Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study-II)

Apr 12, 2011·Diabetes, Obesity & Metabolism·D S H BellR B Sawakhande

Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials

Apr 20, 2011·Annals of Internal Medicine·Faramarz Ismail-BeigiSaul Genuth

Glycemic control, complications, and death in older diabetic patients: the diabetes and aging study

Apr 21, 2011·Diabetes Care·Elbert S HuangAndrew J Karter

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis

May 18, 2011·Annals of Internal Medicine·Jorge L GrossDiabetes and Endocrinology Meta-analysis Group (DEMA)

Associations between general and abdominal adiposity and mortality in individuals with diabetes mellitus

May 28, 2011·American Journal of Epidemiology·Diewertje SluikUte Nöthlings

Use of metformin in the setting of mild-to-moderate renal insufficiency

May 28, 2011·Diabetes Care·Kasia J LipskaSilvio E Inzucchi

Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study

Jun 18, 2011·Diabetes, Obesity & Metabolism·David R OwensMatthew C Riddle

Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial

Aug 13, 2011·Diabetes Care·Jessica L UnickLook AHEAD Research Group

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis

Mar 14, 2012·BMJ : British Medical Journal·Thomas KaragiannisApostolos Tsapas

Citations

Obesity in the elderly: clinical relevance and therapy options

Jun 20, 2013·Zeitschrift für Gerontologie und Geriatrie·Monika Lechleitner

Diabetes and osteoporosis: pathophysiological interactions and clinical importance for geriatric patients

Jul 19, 2013·Zeitschrift für Gerontologie und Geriatrie·Monika LechleitnerP Pietschmann

Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study

Jan 25, 2013·Journal of General Internal Medicine·Gregory A NicholsShreekant Parasuraman

Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries

Feb 14, 2013·Journal of General Internal Medicine·Naomi C SacksMarie E McDonnell

Management of post-transplant diabetes

Nov 29, 2012·Current Diabetes Reports·Ashley TherasseMark E Molitch

Personalized decision support in type 2 diabetes mellitus: current evidence and future directions

Nov 20, 2012·Current Diabetes Reports·Michael J WilkinsonElbert S Huang

Insulin use early in the course of type 2 diabetes mellitus: the ORIGIN trial

Feb 12, 2013·Current Diabetes Reports·Markolf Hanefeld, Peter Bramlage

Diabetes and HIV: current understanding and future perspectives

Mar 1, 2013·Current Diabetes Reports·Sanjay Kalra, Navneet Agrawal

Risk vs benefit in diabetes pharmacotherapy: a rational approach to choosing pharmacotherapy in type 2 diabetes

Mar 21, 2013·Current Diabetes Reports·Mary Elizabeth Cox, Mark N Feinglos

The place of GLP-1-based therapy in diabetes management: differences between DPP-4 inhibitors and GLP-1 receptor agonists

Mar 13, 2013·Current Diabetes Reports·Dara L Eckerle Mize, Marzieh Salehi

Impact of behavioral interventions in the management of adults with type 2 diabetes mellitus

Sep 28, 2013·Current Diabetes Reports·Daniel J CoxWilliam S Yancy

Proton pump inhibitors: impact on glucose metabolism

Aug 14, 2012·Endocrine·Diana Boj-Carceller

Insulin therapy for type 2 diabetes

Oct 30, 2012·Endocrine·Luigi Meneghini

Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

Jan 29, 2013·Endocrine·Sachin K Majumdar, Silvio E Inzucchi

Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes?

Mar 13, 2013·Endocrine·Katherine EspositoD Giugliano

Initial combination with linagliptin and metformin in newly diagnosed type 2 diabetes and severe hyperglycemia

Dec 6, 2012·Advances in Therapy·Thomas Haak

Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes

Feb 21, 2013·Advances in Therapy·Michael HorowitzKaren L Jones

Complementing insulin therapy to achieve glycemic control

Jun 26, 2013·Advances in Therapy·Anthony H Barnett

The dipeptidyl peptidase (DPP)-4 inhibitors for type 2 diabetes mellitus in challenging patient groups

Nov 30, 2013·Advances in Therapy·David S Kountz

The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy

Dec 3, 2013·Advances in Therapy·Sarah ThayerRobert M Cuddihy

Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE

Aug 29, 2012·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Andreas LieblHelen T Smith

Safety and effectiveness of insulin detemir in different age-groups in the a1chieve study

May 15, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Rachid MalekLeon Litwak

Safety and effectiveness of insulin aspart in Basal-bolus regimens regardless of age: a1chieve study results

May 15, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Zafar Ahmed LatifPradana Soewondo

Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studies

May 24, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Samuel S EngelBarry J Goldstein

Safety and effectiveness of bolus insulin aspart in people with type 2 diabetes: a1chieve sub-analysis

Jun 13, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Hoosen RandereeJihad Haddad

Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures

Jul 25, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Joel M NeutelChetan S Karyekar

Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple rising doses of empagliflozin in patients with type 2 diabetes mellitus

Jul 11, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Tim HeiseKlaus Dugi

Safety and Effectiveness of Switching from a Basal-only to Biphasic Insulin Aspart 30 Insulin Regimen

Jul 13, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jihad HaddadPradana Soewondo

Initial management of severe hyperglycemia in patients with type 2 diabetes: an observational study

Aug 21, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·William M KingJennifer M Trujillo

Incretin-based therapies: focus on effects beyond glycemic control alone

Sep 24, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Jaime A Davidson

Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus

Oct 22, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Harold Bays

Incretin therapy for type 2 diabetes in Spain: a cost-effectiveness analysis of liraglutide versus sitagliptin

Oct 18, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Pedro Mezquita RayaWilliam J Valentine

Age-specific effectiveness and safety of newly initiated insulin therapy in Japanese patients with uncontrolled diabetes

Dec 11, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Takayoshi ShigaHiroshi Isonuma

Lixisenatide: a review of its use in patients with type 2 diabetes mellitus

Aug 7, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Lesley J Scott

Pharmacokinetics of a fixed-dose combination of mitiglinide and metformin versus concurrent administration of individual formulations in healthy subjects: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover study

Oct 27, 2012·Clinical Drug Investigation·Jin Ah JungWooseong Huh

Saxagliptin add-on therapy to insulin with or without metformin for type 2 diabetes mellitus: 52-week safety and efficacy

Aug 21, 2013·Clinical Drug Investigation·Anthony H BarnettNayyar Iqbal

Canagliflozin: first global approval

Jun 4, 2013·Drugs·Shelley Elkinson, Lesley J Scott

Targeting hyperglycaemia with anti-obesity drugs: time for a paradigm shift?

Oct 5, 2013·Drugs·Andrew J Krentz, Marcus Hompesch

Observational study of once-daily insulin detemir in people with type 2 diabetes aged 75 years or older: a sub-analysis of data from the Study of Once daily LeVEmir (SOLVE)

Feb 2, 2013·Drugs & Aging·Eddy KarnieliSOLVE Study Group

Elderly patients with diabetes experience a lower rate of nocturnal hypoglycaemia with insulin degludec than with insulin glargine: a meta-analysis of phase IIIa trials

Oct 31, 2013·Drugs & Aging·Christopher SorliStephen C L Gough

Patient preferences for the treatment of type 2 diabetes: a scoping review

Oct 2, 2013·PharmacoEconomics·Susan M JoyJohn F P Bridges

Results from the UK cohort of SOLVE: providing insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

Jan 1, 2014·Primary Care Diabetes·Kamlesh KhuntiMelanie Davies

Inhibition of dipeptidyl peptidase (DPP)-IV and α-glucosidase activities by pepsin-treated whey proteins

Jul 11, 2013·Journal of Agricultural and Food Chemistry·Isabelle M E Lacroix, Eunice C Y Li-Chan

Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes

May 18, 2013·Journal of Medicinal Chemistry·Yulin WuJon L Collins

Mechanisms of acute coronary syndromes

Aug 30, 2013·The New England Journal of Medicine·Peter Libby

Clinical practice. Diagnosis of diabetes

Aug 10, 2012·The New England Journal of Medicine·Silvio E Inzucchi

Achievement of goals in U.S. diabetes care, 1999-2010

Apr 26, 2013·The New England Journal of Medicine·Mohammed K AliEdward W Gregg

Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model

Dec 26, 2012·Proceedings of the National Academy of Sciences of the United States of America·Tie-Jun Sten ShiTomas G M Hökfelt

Predicting outcomes and assessing control with alternate glycemic markers

Aug 30, 2012·Diabetes Technology & Therapeutics·Kathleen M Dungan

Glimepiride strongly enhances the glucose-lowering effect in triple oral antidiabetes therapy with sitagliptin and metformin for Japanese patients with type 2 diabetes mellitus

Mar 14, 2013·Diabetes Technology & Therapeutics·Keiko AraiKoichi Hirao

Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes

Jun 22, 2013·Diabetes Technology & Therapeutics·David R Owens

An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology

Aug 10, 2013·Diabetes Technology & Therapeutics·Evis HarjaJay S Skyler

Cardiovascular disease and the use of insulin

Sep 3, 2013·Diabetes Technology & Therapeutics·Caroline K Kramer, Bernard Zinman

Comments on Petrak et al.'s "psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin": considerations for language and communication

Nov 1, 2013·Diabetes Technology & Therapeutics·Elizabeth Holmes-Truscott, Jane Speight

Rapid oxalate determination in blood and synthetic urine using a newly developed oxometer

Sep 15, 2012·Journal of Endourology·Benjamin K CanalesAmmon B Peck

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II

Apr 30, 2013·European Heart Journal·Joshua A BeckmanMark A Creager

Insulin therapy attitudes and beliefs of physicians in Middle Eastern Arab countries

Jun 5, 2013·Family Practice·Najla A LakkisGhassan N Hamadeh

Lipoprotein abnormalities in patients with type 2 diabetes and metabolic syndrome

Aug 8, 2013·JAAPA : Official Journal of the American Academy of Physician Assistants·Tania Dickson-HumphriesSusan Kuntz

Management of type 2 diabetes

May 23, 2013·The Nurse Practitioner·Stacey Seggelke, Bridget Everhart

New antidiabetic therapies: innovative strategies for an old problem

Oct 17, 2012·Current Opinion in Lipidology·Michael Lehrke, Nikolaus Marx

GLP-1 receptor activated insulin secretion from pancreatic β-cells: mechanism and glucose dependence

Jul 11, 2012·Diabetes, Obesity & Metabolism·Alison MeloniD G Parkes

Poor glycemic control in younger women attending Malaysian public primary care clinics: findings from adults diabetes control and management registry

Dec 12, 2013·BMC Family Practice·Ai Theng CheongMat-Nasir Nafiza

Design of a trial to evaluate the impact of clinical pharmacists and community health promoters working with African-Americans and Latinos with diabetes

Oct 24, 2012·BMC Public Health·Ben S GerberLisa K Sharp

Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables

Jun 27, 2013·BMC Public Health·Linong JiYan-Cheng Xu

Efficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studies

Mar 5, 2013·BMC Endocrine Disorders·Asres Berhan, Yifru Berhan

Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice - study rationale and protocol of DIALOGUE

Dec 12, 2012·Cardiovascular Diabetology·Anselm K GittDIALOGUE study group

Rationale, design and baseline characteristics of a 4-year (208-week) phase III trial of empagliflozin, an SGLT2 inhibitor, versus glimepiride as add-on to metformin in patients with type 2 diabetes mellitus with insufficient glycemic control

Sep 7, 2013·Cardiovascular Diabetology·Martin RidderstråleEMPA-REG H2H-SU trial investigators

Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study

Sep 10, 2013·Cardiovascular Diabetology·Ryuzo KawamoriYoshitomo Oka

Personalizing guidelines for diabetes management: twilight or dawn of the expert?

Jul 12, 2013·BMC Medicine·Stavroula A Paschou, Richard David Leslie

Electroacupuncture to treat painful diabetic neuropathy: study protocol for a three-armed, randomized, controlled pilot trial

Jul 23, 2013·Trials·Seunghoon LeeSun-Mi Choi

Are diabetes management guidelines applicable in 'real life'?

Nov 23, 2012·Diabetology & Metabolic Syndrome·Luciana V VianaJorge L Gross

Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment

May 24, 2013·Diabetology & Metabolic Syndrome·Erika Paniago GuedesFelipe Lauand

Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice

Aug 7, 2013·Diabetology & Metabolic Syndrome·Nicholas TentolourisBarbara Baroutsou

Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study

Nov 16, 2013·Diabetology & Metabolic Syndrome·Leon LitwakMohammad E Khamseh

Prevalence, sociodemographic distribution, treatment and control of diabetes mellitus in Panama

Feb 7, 2014·Diabetology & Metabolic Syndrome·Anselmo J Mc Donald PAlberto Cumbrera O

Comparative efficacy of glimepiride and metformin in monotherapy of type 2 diabetes mellitus: meta-analysis of randomized controlled trials

Nov 16, 2013·Diabetology & Metabolic Syndrome·Hongmei ZhuSiu-Wai Leung

Patient centred care in diabetology: an Islamic perspective from South Asia

Jan 1, 2012·Journal of Diabetes and Metabolic Disorders·Asfandyar K Niazi, Sanjay Kalra

Year in diabetes 2012: The diabetes tsunami

Nov 28, 2012·The Journal of Clinical Endocrinology and Metabolism·R Sherwin, A M Jastreboff

Thyroid cancer risk is not increased in diabetic patients

Jan 10, 2013·PloS One·Chin-Hsiao Tseng

Learning theories reveal loss of pancreatic electrical connectivity in diabetes as an adaptive response

Aug 13, 2013·PloS One·Pranay Goel, Anita Mehta

The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study

Sep 11, 2013·PloS One·Kirsten E PetersTimothy M E Davis

The longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary care

Nov 14, 2013·PloS One·Giesje NefsFrançois Pouwer

Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials

Feb 18, 2014·PloS One·Gijs W D LandmanNanne Kleefstra

Increase in direct diabetes-related costs and resource use in the 6 months following initiation of insulin in patients with type 2 diabetes in five European countries: data from the INSTIGATE study

Jan 2, 2013·ClinicoEconomics and Outcomes Research : CEOR·Stephen JonesCarole Salaun-Martin

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

Apr 30, 2013·Clinical Interventions in Aging·Chetan S KaryekarRobert Frederich

A review of sitagliptin with special emphasis on its use in moderate to severe renal impairment

Sep 17, 2013·Drug Design, Development and Therapy·Vinay S Eligar, Stephen C Bain

Dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapy--focus on alogliptin

Sep 27, 2013·Drug Design, Development and Therapy·Annalisa CapuanoKatherine Esposito

Canagliflozin: a novel treatment option for type 2 diabetes

Nov 29, 2013·Drug Design, Development and Therapy·Eric DietrichJames R Taylor

Glucagon-like peptide-1 receptor agonists as add-on therapy to basal insulin in patients with type 2 diabetes: a systematic review

Jul 25, 2012·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Helen BerlieNicole R Pinelli

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes

Nov 10, 2013·Vascular Health and Risk Management·Karoline von WebskyBerthold Hocher

Exenatide extended-release: a review of its use in type 2 diabetes mellitus

Aug 8, 2012·Drugs·Lesley J Scott

Dapagliflozin: a review of its use in type 2 diabetes mellitus

Nov 23, 2012·Drugs·Greg L Plosker

Understanding patient portal use: implications for medication management

Jul 5, 2013·Journal of Medical Internet Research·Chandra Y OsbornTom Elasy

InsuOnline, a Serious Game to Teach Insulin Therapy to Primary Care Physicians: Design of the Game and a Randomized Controlled Trial for Educational Validation

Apr 25, 2013·JMIR Research Protocols·Leandro A DiehlIzabel C M M Coelho

The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy

Nov 20, 2012·Diabetes Care·Pascale FouquerayHarold E Lebovitz

Standards of medical care in diabetes--2013

Jan 4, 2013·Diabetes Care·American Diabetes Association

National standards for diabetes self-management education and support

Feb 8, 2013·Diabetes Care·Linda Haas2012 Standards Revision Task Force

Lessons from mouse models of high-fat diet-induced NAFLD

Nov 29, 2013·International Journal of Molecular Sciences·Akinobu Nakamura, Yasuo Terauchi

Role of insulin in the type 2 diabetes therapy: past, present and future

Dec 19, 2013·International Journal of Endocrinology and Metabolism·Carlo Maria RotellaEdoardo Mannucci

A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes

Apr 11, 2014·PloS One·Laura R SaslowFredrick M Hecht

Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies

Apr 17, 2014·BMJ : British Medical Journal·Ling LiXin Sun

Linagliptin: from bench to bedside

May 23, 2014·Drug Design, Development and Therapy·John Doupis

Low socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE)

May 27, 2014·Journal of Health Care for the Poor and Underserved·Seth A BerkowitzUrmimala Sarkar

Treatment pattern of type 2 diabetes differs in two German regions and with patients' socioeconomic position

Jun 11, 2014·PloS One·T TamayoAndrea Icks

How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study

Jun 27, 2014·Vascular Health and Risk Management·Alfred PenfornisSylvie Dejager

Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly

Jun 28, 2014·Drug Design, Development and Therapy·Antoni Sicras-Mainar, Ruth Navarro-Artieda

Comparison of GLP-1 analogues versus sitagliptin in the management of type 2 diabetes: systematic review and meta-analysis of head-to-head studies

Aug 5, 2014·PloS One·Tiansheng WangSuo-di Zhai

Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥ 65 years) with type 2 diabetes

Sep 13, 2014·Clinical Interventions in Aging·Nayyar IqbalPeter Öhman

Liraglutide, a glucagon-like peptide-1 analog, increased insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp examination in patients with uncontrolled type 2 diabetes mellitus

Apr 30, 2015·Journal of Diabetes Research·Hideaki JinnouchiTomio Jinnouchi

An accidental liraglutide overdose: case report

Jan 28, 2014·The Libyan Journal of Medicine·Rafik R Elmehdawi, Abdulwahab M Elbarsha

The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

Jan 1, 2014·Nature Reviews. Nephrology·Marcel H A MuskietMichaela Diamant

Sitagliptin: a review of its use in patients with type 2 diabetes mellitus

Jan 11, 2014·Drugs·Greg L Plosker

Exenatide twice daily: a review of its use in the management of patients with type 2 diabetes mellitus

Jan 18, 2014·Drugs·Paul L McCormack

Rational use of electronic health records for diabetes population management

Mar 13, 2014·Current Diabetes Reports·Emma M Eggleston, Michael Klompas

Comparing patient preferences and healthcare provider recommendations with the pen versus vial-and-syringe insulin delivery in patients with type 2 diabetes

Nov 26, 2013·Diabetes Technology & Therapeutics·Andrew AhmannSatish K Garg

Platelet function and hyperglycemia in acute coronary syndrome

Apr 30, 2014·Revista Española De Cardiología·Manel Puig Domingo

Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database

Feb 5, 2014·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Ryogo UmetsuMitsuhiro Nakamura

Sulfonylureas: a new look at old therapy

Feb 25, 2014·Current Diabetes Reports·Peter M Thulé, Guillermo E Umpierrez

Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol

Feb 18, 2014·Implementation Science : IS·John FurlerIrene Blackberry

Lessons from the look action for health in diabetes study

Jun 10, 2014·Indian Journal of Endocrinology and Metabolism·Mary T Korytkowski

Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials

Feb 5, 2014·Cardiovascular Diabetology·Nayyar IqbalBoaz Hirshberg

An update on the pharmacogenomics of metformin: progress, problems and potential

Mar 15, 2014·Pharmacogenomics·Jennifer N Todd, Jose C Florez

Heterogeneity in the costs of type 1 diabetes in a developing country: what are the determining factors?

Jan 1, 2014·Diabetology & Metabolic Syndrome·Roberta Arnoldi CobasBrazilian Type 1 Diabetes Study Group (BrazDiab1SG)

Diabetes education: "Personal" family member or "impersonal" diabetes educator?

Oct 2, 2013·Indian Journal of Endocrinology and Metabolism·Jaikrit BhutaniJ K Bhutani

Trends in insulin initiation and treatment intensification among patients with type 2 diabetes

Oct 9, 2013·Journal of General Internal Medicine·Amanda R PatrickJennifer M Polinski

Safety, pharmacokinetics, and pharmacodynamics of single and multiple luseogliflozin dosing in healthy Japanese males: a randomized, single-blind, placebo-controlled trial

Feb 19, 2014·Advances in Therapy·Takashi SasakiYoshishige Samukawa

Real-world cost-effectiveness: lower cost of treating patients to glycemic goal with liraglutide versus exenatide

Jan 31, 2014·Advances in Therapy·Mitch DeKovenJakob Langer

Hospital readmission and emergency department use based on prescribing patterns in patients with severely uncontrolled type 2 diabetes mellitus

Nov 15, 2013·Diabetes Technology & Therapeutics·Phillip H LeeMichelle Zingone Farland

A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy

Feb 26, 2014·BMC Endocrine Disorders·Judith L WhiteRobert Frederich

Subetta treatment increases adiponectin secretion by mature human adipocytes in vitro

May 22, 2013·International Journal of Endocrinology·Jim NicollOleg I Epstein

Paradoxical insights into whole body metabolic adaptations following SGLT2 inhibition

Jan 28, 2014·The Journal of Clinical Investigation·William T Cefalu

Comparison of two creatinine-based equations for predicting decline in renal function in type 2 diabetic patients with nephropathy in a korean population

Jan 24, 2014·International Journal of Endocrinology·Eun Young LeeBeom Seok Kim

Capsule commentary on Patrick et al., trends in insulin initiation and treatment intensification among patients with type 2 diabetes

Oct 19, 2013·Journal of General Internal Medicine·François R Jornayvaz

Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study

Mar 7, 2014·BMC Endocrine Disorders·Stavros LiatisStavros Pappas

Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients

May 11, 2013·European Journal of Endocrinology·Simona BoGiovannino Ciccone

Effects of switching from NPH insulin to insulin glargine in patients with type 2 diabetes: the retrospective, observational LAUREL study in Italy

Nov 28, 2013·Acta Diabetologica·Alfonso BelliaRenato Lauro

Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes

Feb 11, 2014·Acta Diabetologica·Chin-Hsiao Tseng

Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes

Jan 22, 2014·Pharmacogenomics·Jazlina Liza JamaluddinNorlaila Mustafa

Thyroid safety in patients treated with liraglutide

Mar 14, 2013·Journal of Endocrinological Investigation·M Gallo

Incorporating incretin-based therapies into clinical practice for patients with type 2 diabetes

Feb 19, 2014·Advances in Therapy·Joseph Tibaldi

Predictors of response to early basal insulin treatment in patients with type 2 diabetes--the EARLY experience

Nov 16, 2013·Diabetes Technology & Therapeutics·Markolf HanefeldPeter Bramlage

Safety and efficacy of colesevelam HCl in the treatment of elderly patients

Apr 30, 2014·Drugs & Aging·James R GavinKenneth E Truitt

The evolution of insulin glargine and its continuing contribution to diabetes care

May 29, 2014·Drugs·Rolf HilgenfeldDavid R Owens

Both glimepiride and high-dose metformin are important for sustained glucose lowering in Japanese type 2 diabetes patients on glimepiride-sitagliptin-metformin therapy: subanalysis of a single-center, open-label, randomized study

Feb 18, 2014·Diabetes Technology & Therapeutics·Keiko AraiKoichi Hirao

Impairment of executive cognitive control in type 2 diabetes, and its effects on health-related behavior and use of health services

Feb 23, 2013·Journal of Behavioral Medicine·Dinh TranJim Grigsby

Stepping up: a nurse-led model of care for insulin initiation for people with type 2 diabetes

Jan 30, 2014·Family Practice·John FurlerJames Best

Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve study

Jan 31, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Issam HajjajiPhilip Home

Type 2 diabetes mellitus management and body mass index: experiences with initiating insulin detemir in the a1chieve study

Jan 31, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Mohammed E KhamsehAlexey Zilov

Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis

Apr 5, 2014·Journal of Endocrinological Investigation·Edoardo MannucciMassimo Porta

Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study

Apr 2, 2014·Diabetology & Metabolic Syndrome·Noriko IhanaMitsuhiko Noda

Achieving glycaemic targets with basal insulin in T2DM by individualizing treatment

Feb 19, 2014·Nature Reviews. Endocrinology·Vivian Fonseca, Michelle A Haggar

Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study

Apr 15, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·D SimonSylvie Dejager

SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes)

Jan 2, 2014·Endocrine·Ernesto Maddaloni, Paolo Pozzilli

Dapagliflozin added to glimepiride in patients with type 2 diabetes mellitus sustains glycemic control and weight loss over 48 weeks: a randomized, double-blind, parallel-group, placebo-controlled trial

Jun 13, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Krzysztof StrojekS Parikh

Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes

Mar 14, 2014·Endocrine Journal·Guoyue YuanChaoming Mao

Insulin therapy and cancer in type 2 diabetes

Dec 5, 2012·ISRN Endocrinology·Edoardo Mannucci

Efficacy of adding once- and thrice-daily voglibose in Japanese type 2 diabetic patients treated with alogliptin

Feb 25, 2014·Endocrine Journal·Mitsuyoshi TakaharaIichiro Shimomura

Behavioral health coaching for rural veterans with diabetes and depression: a patient randomized effectiveness implementation trial

Apr 30, 2014·BMC Health Services Research·Jeffrey A CullyAanand D Naik

Post-meal β-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin monotherapy after addition of glibenclamide or acarbose

Jun 17, 2014·Diabetology & Metabolic Syndrome·Po-Hsun ChenShih-Yi Lin

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes

Mar 4, 2014·Diabetologia·David PolidoriEle Ferrannini

Pharmacokinetic and pharmacodynamic interaction between gemigliptin and metformin in healthy subjects

Mar 15, 2014·Clinical Drug Investigation·Dongseong ShinKyung-Sang Yu

Vildagliptin: a review of its use in type 2 diabetes mellitus

Mar 19, 2014·Drugs·Gillian M Keating

Glycemic control in a 79-year-old female with mild cognitive impairment using a medication reminder device: a case report

Jan 3, 2014·International Psychogeriatrics·T Kamimura, H Ito

Real-life effectiveness and tolerability of vildagliptin and other oral glucose-lowering therapies in patients with type 2 diabetes in Germany

Mar 20, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·R GökeM Dworak

Baseline glycemic parameters predict the hemoglobin A1c response to DPP-4 inhibitors : meta-regression analysis of 78 randomized controlled trials with 20,053 patients

Nov 20, 2013·Endocrine·Katherine EspositoD Giugliano

Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined Phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study

Apr 1, 2014·Cardiovascular Diabetology·Kohei KakuTofogliflozin 003 Study Group

An exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocol

Jun 3, 2014·BMC Family Practice·Irene BlackberryDavid O'Neal

Efficacy of liraglutide in a real-life cohort

Mar 26, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Anthony HeymannAvraham Karasik

Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality

Apr 25, 2014·Intensive Care Medicine·Mark P PlummerAdam M Deane

Canagliflozin: a review of its use in patients with type 2 diabetes mellitus

May 17, 2014·Drugs·Greg L Plosker

Observational study on dipeptidyl peptidase-4 inhibitors: a real-life analysis on 360 patients from the ASL VCO territory in Italy

May 3, 2014·Clinical Drug Investigation·Giuseppe SagliettiAntonella Schellino

Metabolic effects of Basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: registry-based observational study in clinical practice

May 16, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Björn EliassonAnn-Marie Svensson

Early discontinuation and restart of insulin in the treatment of type 2 diabetes mellitus

May 2, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Haya Ascher-SvanumMichael Treglia

Pharmacokinetic and pharmacodynamic profiles of canagliflozin in Japanese patients with type 2 diabetes mellitus and moderate renal impairment

Sep 10, 2014·Clinical Drug Investigation·Nobuya InagakiKenichi Furihata

Empagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, 12-week, double-blind, placebo-controlled, phase II trial

Jun 25, 2014·Advances in Therapy·Takashi KadowakiUli C Broedl

Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications

Jun 22, 2014·Cardiovascular Drugs and Therapy·Barak Zafrir, Mohit Jain

Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network

Jan 22, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Carmen FerrajoloEU-ADR consortium

Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis

Apr 17, 2014·Diabetes Technology & Therapeutics·Lin XieOnur Baser

Switching from insulin to liraglutide improved glycemic control and the quality of life scores in a case of type 2 diabetes and active Crohn's disease

Aug 5, 2014·Internal Medicine·Hirohito KuwataHitoshi Ishii

ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients

Feb 18, 2014·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Massimo VolpeAthanasios J Manolis

Lixisenatide treatment for older patients with type 2 diabetes mellitus uncontrolled on oral antidiabetics: meta-analysis of five randomized controlled trials

Aug 22, 2014·Advances in Therapy·Markolf HanefeldLuc van Gaal

Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

Jul 23, 2014·BMC Endocrine Disorders·Taner DamciSOLVE™ study group

Diabetes: safety and efficacy of albiglutide-results from two trials

Jul 30, 2014·Nature Reviews. Endocrinology·Giuseppe Derosa, Pamela Maffioli

Duration of diabetes and effectiveness of insulin in the management of insulin-naïve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry results

Mar 1, 2014·Acta Diabetologica·Sang Soo KimKyoung Soo Ha

Diet control to achieve euglycemia induces significant loss of heart and liver weight via increased autophagy compared with ad libitum diet in diabetic rats

Aug 30, 2014·Experimental & Molecular Medicine·Jun-Ho LeeYun-Hee Noh

The use of clinical guidelines highlights ongoing educational gaps in physicians' knowledge and decision making related to diabetes

Sep 10, 2014·BMC Medical Education·Mark D CorriereRita Rastogi Kalyani

Management of elderly patients with type 2 diabetes mellitus

Jul 8, 2014·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Kenzo Oba

Indirect bioequivalence assessment using network meta-analyses

May 20, 2014·European Journal of Clinical Pharmacology·A RingR Schall

Pioglitazone: Hype and hope

Aug 15, 2014·Journal of Postgraduate Medicine·S S JadhavN S Shah

Cost effectiveness of adding dapagliflozin to insulin for the treatment of type 2 diabetes mellitus in the Netherlands

Nov 19, 2013·Clinical Drug Investigation·Heleen G M van HaalenM Roudaut

Efficacy and safety of canagliflozin in subjects with type 2 diabetes: systematic review and meta-analysis

Aug 16, 2014·European Journal of Clinical Pharmacology·Xu-Ping YangYi-Lan Huang

Diabetes patients' experiences with the implementation of insulin therapy and their perceptions of computer-assisted self-management systems for insulin therapy

Oct 24, 2014·Journal of Medical Internet Research·Airin Cr SimonNiels Peek

Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes

Oct 29, 2014·Diabetology & Metabolic Syndrome·Kenjiro ImaiMitsuhiko Noda

Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial

Jul 19, 2014·Diabetes Technology & Therapeutics·David J KleinNN2211-1800 Study Group

Clinical utility of dipeptidyl peptidase-4 inhibitors: a descriptive summary of current efficacy trials

Sep 2, 2014·European Journal of Clinical Pharmacology·George Grunberger

Cost effectiveness of liraglutide in type II diabetes: a systematic review

Jul 24, 2014·PharmacoEconomics·Patrick M ZuegerTodd A Lee

Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozin

Oct 16, 2014·Clinical Pharmacokinetics·Takeshi KadokuraRonald Smulders

Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a ≥52-week randomized, double-blind study

Sep 26, 2013·Diabetes Care·H Yki-JärvinenHans-Juergen Woerle

Diabetes guidelines may delay timely adjustments during treatment and might contribute to clinical inertia

Jun 4, 2014·Diabetes Technology & Therapeutics·Augusto Pimazoni-Netto, Maria Teresa Zanella

Understanding incretins

Aug 21, 2014·Intensive Care Medicine·Adam M Deane, Palle B Jeppesen

Optical control of insulin release using a photoswitchable sulfonylurea

Oct 15, 2014·Nature Communications·Johannes BroichhagenDirk Trauner

Clinical evidence for metabolic surgery

Oct 16, 2014·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·J D SenftB P Müller-Stich

Empagliflozin: a review of its use in patients with type 2 diabetes mellitus

Oct 3, 2014·Drugs·Lesley J Scott

Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage

Nov 2, 2014·BMC Cardiovascular Disorders·Luis A VázquezJesus Reviriego

Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerations

Nov 22, 2014·Drugs·Nicholas W CarrisJohn G Gums

A Low-Intensity Mobile Health Intervention With and Without Health Counseling for Persons With Type 2 Diabetes, Part 1: Baseline and Short-Term Results From a Randomized Controlled Trial in the Norwegian Part of RENEWING HEALTH

Dec 17, 2014·JMIR MHealth and UHealth·Astrid TorbjørnsenLis Ribu

Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes

Nov 23, 2013·Diabetes Care·Francesca PorcellatiCarmine G Fanelli

Clinical course and outcomes of type-2 diabetic patients after treatment intensification for insufficient glycaemic control - results of the 2 year prospective DiaRegis follow-up

Nov 21, 2014·BMC Cardiovascular Disorders·Peter BramlageDiethelm Tschöpe

The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies

Sep 28, 2014·BMC Cardiovascular Disorders·Cristina Varas-LorenzoSusana Perez-Gutthann

Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus

Nov 5, 2014·Drugs·Lesley J Scott

The effect of glibenclamide on insulin secretion at normal glucose concentrations

Oct 10, 2014·Diabetologia·Axel RiefflinJonathan C Levy

Insulin resistance, diabetes, and cardiovascular risk

May 2, 2014·Current Atherosclerosis Reports·Francesco PaneniFrancesco Cosentino

Comparative effects of metformin and pioglitazone on YKL-40 in type 2 diabetes: a randomized clinical trial

Aug 21, 2014·Journal of Endocrinological Investigation·A EsteghamatiS Noshad

Glucemic control in patients with type 2 diabetes mellitus in Spain: Quo vadis?

Jul 9, 2014·Revista clínica española·M S Ruiz de Adana, F Soriguer

Does gestational diabetes result in cochlear damage?

Nov 18, 2014·The Journal of Laryngology and Otology·A SelcukS Genc

HARMONY 4: randomised clinical trial comparing once-weekly albiglutide and insulin glargine in patients with type 2 diabetes inadequately controlled with metformin with or without sulfonylurea

Sep 12, 2014·Diabetologia·Peter N WeissmanRichard E Pratley

Dapagliflozin: a review of its use in patients with type 2 diabetes

Nov 13, 2014·Drugs·Greg L Plosker

A Virtual World Versus Face-to-Face Intervention Format to Promote Diabetes Self-Management Among African American Women: A Pilot Randomized Clinical Trial

Oct 26, 2014·JMIR Research Protocols·Milagros C RosalJohn M Wiecha

Pharmacological treatment and therapeutic perspectives of metabolic syndrome

Oct 25, 2014·Reviews in Endocrine & Metabolic Disorders·Soo Lim, Robert H Eckel

Healthcare costs of the combination of metformin/dipeptidyl peptidase-4 inhibitors compared with metformin/other oral antidiabetes agents in patients with type 2 diabetes and metabolic syndrome

Aug 5, 2014·Diabetes Technology & Therapeutics·Antoni Sicras-Mainar, Ruth Navarro-Artieda

Relationships between gastric emptying, postprandial glycemia, and incretin hormones

Apr 25, 2013·Diabetes Care·Chinmay S MaratheMichael Horowitz

Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum

May 25, 2013·Diabetes Care·Itamar RazWilliam T Cefalu

Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action

Jun 27, 2013·Diabetes Care·Boris DrazninDeborah J Wexler

Incorporating lag time to benefit into prevention decisions for older adults

Dec 11, 2013·JAMA : the Journal of the American Medical Association·Sei J LeeLouise C Walter

Comparison between the therapeutic effect of metformin, glimepiride and their combination as an add-on treatment to insulin glargine in uncontrolled patients with type 2 diabetes

Mar 13, 2014·PloS One·Cheol-Young ParkSung Woo Park

Insulin therapy of diabetes

Dec 20, 2012·Wiener klinische Wochenschrift·Monika LechleitnerThomas C Wascher

Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes

Sep 4, 2012·Current Cardiology Reports·Niina Matikainen, Marja-Riitta Taskinen

Trialogue Plus: Management of cardiovascular risk in hyperglycaemic/diabetic patients at hospital discharge

Oct 15, 2013·Acta Diabetologica·Giampietro BeltramelloAngela Rivellese

Current treatment of type 2 diabetes

Nov 28, 2012·Der Internist·Guntram Schernthaner, G-H Schernthaner

Efficacy and safety of dipeptidyl peptidase-4 inhibitors in combination with metformin

Apr 23, 2013·Advances in Therapy·Andrea D Fass, Jennifer A Gershman

Effects of Age on Glycemic Control in Patients With Type 2 Diabetes Treated with Insulin Detemir: A Post-Hoc Analysis of the PREDICTIVE™ 303 Study

Feb 3, 2016·Drugs & Aging·Anuj BhargavaDavid S Oyer

Maintenance of Clinical Endpoints After Discharge from a Pharmacist-Managed Risk Reduction Clinic at a Veterans Affairs Medical Center

Mar 26, 2016·Journal of Managed Care & Specialty Pharmacy·Christina H SherrillEmily E Wood

Impact of sodium glucose cotransporter 2 inhibitors on weight in patients with type 2 diabetes mellitus

Oct 12, 2013·Postgraduate Medicine·Anthony H Barnett

Exenatide once weekly versus daily basal insulin as add-on treatment to metformin with or without a sulfonylurea: a retrospective pooled analysis in patients with poor glycemic control

Oct 12, 2013·Postgraduate Medicine·Michael GrimmErich Blase

The impact of weight loss on weight-related quality of life and health satisfaction: results from a trial comparing canagliflozin with sitagliptin in triple therapy among people with type 2 diabetes

Jun 12, 2014·Postgraduate Medicine·Shana B TrainaApril Slee

Safety and tolerability of canagliflozin in patients with type 2 diabetes mellitus: pooled analysis of phase 3 study results

Jun 12, 2014·Postgraduate Medicine·Keith UsiskinGary Meininger

Effect of renal impairment on the pharmacokinetics, efficacy, and safety of albiglutide

Jun 12, 2014·Postgraduate Medicine·Malcolm A YoungRickey R Reinhardt

Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitus

Jun 12, 2014·Postgraduate Medicine·Michael B Davidson

Evidence-based practice use of incretin-based therapy in the natural history of diabetes

Jun 12, 2014·Postgraduate Medicine·Stanley S Schwartz

Combining clinical judgment with guidelines for the management of type 2 diabetes: overall standards of comprehensive care

Jun 12, 2014·Postgraduate Medicine·Tamer G Yacoub

Application of clinical judgment and guidelines to achieving glycemic goals in type 2 diabetes: focus on pharmacologic therapy

Jun 12, 2014·Postgraduate Medicine·Tamer G Yacoub

Influence of baseline glycemia on outcomes with insulin glargine use in patients uncontrolled on oral agents

Jun 12, 2014·Postgraduate Medicine·Mary Ann BanerjiLawrence Blonde

A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitus

Jun 12, 2014·Postgraduate Medicine·Irl B HirschMatthew C Riddle

Health care provider management of patients with type 2 diabetes mellitus: analysis of trends in attitudes and practices

Jun 12, 2014·Postgraduate Medicine·Chad WilliamsonDaxa Patel

Efficacy and risk of hypoglycemia with use of insulin glargine or comparators in patients with cardiovascular risk factors

Jun 12, 2014·Postgraduate Medicine·Lawrence BlondeMary Ann Banerji

Understanding the type 2 diabetes mellitus and cardiovascular disease risk paradox

Jun 12, 2014·Postgraduate Medicine·Jennifer B Green

Real-world effectiveness of sitagliptin as add-on therapy in patients with type 2 diabetes mellitus

Jun 12, 2014·Postgraduate Medicine·Tse-Ying Chen, Ching-Jung Hsieh

Meeting individualized glycemic targets in primary care patients with type 2 diabetes in Spain

Feb 19, 2016·BMC Endocrine Disorders·I MiñambresAlfonso Perez

Review of empagliflozin monotherapy for previously untreated patients with type 2 diabetes mellitus: Comparison with sitagliptin

Mar 1, 2015·Postgraduate Medicine·Susan Cornell

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in black/African American patients with type 2 diabetes: Pooled analysis from eight Phase III trials

Apr 5, 2015·Postgraduate Medicine·James ThrasherMaximilian von Eynatten

Type 2 diabetes mellitus treatment patterns in U.S. nursing home residents

Apr 9, 2015·Postgraduate Medicine·Barbara ZarowitzAndres DiGenio

Revisiting weight reduction and management in the diabetic patient: Novel therapies provide new strategies

Apr 29, 2015·Postgraduate Medicine·Stanley S Schwartz, Mary Herman

Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus and cardiovascular disease history or cardiovascular risk factors: results of a pooled analysis of phase 3 clinical trials

Jun 12, 2013·Postgraduate Medicine·William CookElsie Allen

A practice-based research network focused on comparative effectiveness research in type 2 diabetes management

Jun 12, 2013·Postgraduate Medicine·John E AndersonDiabetes FORWARD Investigators

Cardiovascular effects of dipeptidyl peptidase-4 inhibitors: from risk factors to clinical outcomes

Jun 12, 2013·Postgraduate Medicine·André J Scheen

Efficacy, safety, and tolerability of exenatide once weekly in patients with type 2 diabetes mellitus: an integrated analysis of the DURATION trials

Jun 12, 2013·Postgraduate Medicine·Michael GrimmJaret Malloy

Efficacy and tolerability of exenatide once weekly versus sitagliptin in patients with type 2 diabetes mellitus: a retrospective analysis of pooled clinical trial data

Jun 12, 2013·Postgraduate Medicine·Jaret MalloyJenny Han

Exenatide once weekly: opportunities in the primary care setting

Jun 12, 2013·Postgraduate Medicine·Jaime A DavidsonMichael Grimm

Clinical utility of the dipeptidyl peptidase-4 inhibitor linagliptin

Jun 12, 2013·Postgraduate Medicine·George Grunberger

Effects of dapagliflozin on cardiovascular risk factors

Jun 12, 2013·Postgraduate Medicine·Agata PtaszynskaJames List

Review of insulin-dependent and insulin-independent agents for treating patients with type 2 diabetes mellitus and potential role for sodium-glucose co-transporter 2 inhibitors

Jun 12, 2013·Postgraduate Medicine·Jeffrey Freeman

Exenatide twice daily: analysis of effectiveness and safety data stratified by age, sex, race, duration of diabetes, and body mass index

Aug 24, 2012·Postgraduate Medicine·Richard PencekPamela W Anderson

Exenatide once weekly for the treatment of type 2 diabetes mellitus: clinical results in subgroups of patients using different concomitant medications

Aug 24, 2012·Postgraduate Medicine·Richard PencekJames K Malone

Hypoglycemic potential of current and emerging pharmacotherapies in type 2 diabetes mellitus

Aug 24, 2012·Postgraduate Medicine·Stephen Brunton

Individualized treatment of type 2 diabetes mellitus using noninsulin agents: clinical considerations for the primary care physician

Aug 24, 2012·Postgraduate Medicine·Nancy J V Bohannon

Pharmacotherapy considerations in diabetes and obesity: setting patients up for success

Apr 2, 2014·Postgraduate Medicine·Susan Cornell, Jennifer D'Souza

Saxagliptin efficacy and safety in patients with type 2 diabetes mellitus stratified by cardiovascular disease history and cardiovascular risk factors: analysis of 3 clinical trials

Nov 22, 2014·Postgraduate Medicine·William CookBoaz Hirshberg

Sodium glucose co-transporter 2 inhibitors and their mechanism for improving glycemia in patients with type 2 diabetes

Nov 22, 2014·Postgraduate Medicine·Jaime A Davidson, Louis Kuritzky

Prandial insulin versus glucagon-like peptide-1 added to basal insulin: comparative effectiveness in the community practice setting

Nov 22, 2014·Postgraduate Medicine·Andres DiGenioMehul R Dalal

Safety and efficacy of dulaglutide, a once weekly GLP-1 receptor agonist, for the management of type 2 diabetes

Nov 22, 2014·Postgraduate Medicine·Louis KuritzkyLaura F Lando

Weight change in patients with type 2 diabetes starting basal insulin therapy: correlates and impact on outcomes

Nov 22, 2014·Postgraduate Medicine·Charles ShaeferRong Zhou

SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem

Jan 8, 2014·Postgraduate Medicine·Serge Jabbour

The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial

Aug 30, 2014·Journal of Medical Economics·Rhodri SaundersWilliam J Valentine

Insulin degludec early clinical experience: does the promise from the clinical trials translate into clinical practice--a case-based evaluation

Oct 18, 2014·Journal of Medical Economics·Marc EvansVolker Foos

Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study

Nov 8, 2013·Journal of Medical Economics·Bradley H Curtis, Maureen J Lage

Cost-effectiveness of metformin plus vildagliptin compared with metformin plus sulphonylurea for the treatment of patients with type 2 diabetes mellitus: a Portuguese healthcare system perspective

Apr 9, 2014·Journal of Medical Economics·Daniel ViriatoRicardo Viana

Evaluation of the long-term cost-effectiveness of liraglutide therapy for patients with type 2 diabetes in France

Sep 29, 2015·Journal of Medical Economics·Ronan RousselWilliam J Valentine

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study

Jul 10, 2013·Journal of Medical Economics·Elizabeth L EbyMaureen J Lage

Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus: a randomized trial

May 18, 2013·Hospital Practice·Bruce W BodeKeith Usiskin

Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?

May 18, 2013·Hospital Practice·Bernard CharbonnelSylvie Dejager

Hypoglycemia in non-critically ill, hospitalized patients with diabetes: evaluation, prevention, and management

Mar 8, 2013·Hospital Practice·Daniel J Rubin, Sherita Hill Golden

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, for the management of type 2 diabetes

Sep 26, 2014·Hospital Practice·Stephen Brunton, Timothy S Reid

Optimal Pharmacologic Treatment Strategies in Obesity and Type 2 Diabetes

Jan 1, 2014·Journal of Clinical Medicine·Gayotri GoswamiNichola Davis

The potential role of sodium glucose co-transporter 2 inhibitors in combination therapy for type 2 diabetes mellitus

Oct 16, 2014·Expert Opinion on Pharmacotherapy·Rosemarie Lajara

Fixed combination of insulin and a glucagon-like peptide-1 analog for the treatment of type 2 diabetes, exemplified by insulin degludec and liraglutide

Mar 31, 2015·Expert Review of Clinical Pharmacology·Louise VedtofteTina Vilsbøll

Alogliptin benzoate for the treatment of type 2 diabetes

Mar 22, 2014·Expert Opinion on Pharmacotherapy·Yutaka Seino, Daisuke Yabe

Use of the dipeptidyl peptidase-4 inhibitor linagliptin in combination therapy for type 2 diabetes

Nov 10, 2012·Expert Opinion on Pharmacotherapy·Rosemarie Lajara

Effects of renal denervation on insulin resistance

Dec 19, 2012·Expert Review of Cardiovascular Therapy·Dagmara HeringMarkus P Schlaich

Cardiovascular risks and benefits with oral drugs for Type 2 diabetes mellitus

Feb 5, 2014·Expert Review of Clinical Pharmacology·Emily Weidman-EvansJeffery D Evans

Can a fixed-ratio combination of insulin degludec and liraglutide help Type 2 diabetes patients to optimize glycemic control across the day?

Feb 24, 2015·Expert Review of Clinical Pharmacology·Richard Simpson, Allen B King

Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus

Nov 3, 2012·Expert Opinion on Pharmacotherapy·Elizabeth M LamosStephen N Davis

Comparison of physician practice patterns for older adults compared to NHANES diabetes cohort on oral/other therapy

Feb 14, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·Fadia T ShayaVerlyn O Warrington

Importance of Beta Cell Function for the Treatment of Type 2 Diabetes

Jan 1, 2014·Journal of Clinical Medicine·Yoshifumi Saisho

Fasiglifam as a new potential treatment option for patients with type 2 diabetes

Nov 8, 2013·Expert Opinion on Pharmacotherapy·Kohei Kaku

Empagliflozin for the treatment of type 2 diabetes

Oct 11, 2014·Expert Opinion on Pharmacotherapy·Vidhya Jahagirdar, Anthony H Barnett

Optimizing glycemic control: lixisenatide and basal insulin in combination therapy for the treatment of Type 2 diabetes mellitus

Oct 24, 2013·Expert Review of Clinical Pharmacology·Ronnie Aronson

A comparison of currently available GLP-1 receptor agonists for the treatment of type 2 diabetes

Jun 26, 2012·Expert Opinion on Pharmacotherapy·Eduard Montanya

Luseogliflozin for the treatment of type 2 diabetes

Nov 2, 2014·Expert Opinion on Pharmacotherapy·Yutaka Seino

Physician perceptions of GLP-1 receptor agonists in the UK

Jan 26, 2016·Current Medical Research and Opinion·Louis S MatzaKristina S Boye

Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes

Feb 20, 2014·Expert Opinion on Drug Metabolism & Toxicology·Stephanie A SteinStephen N Davis

Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions

Sep 27, 2014·Expert Opinion on Drug Metabolism & Toxicology·Erika B Rangel

Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals

Jun 13, 2014·Expert Opinion on Drug Delivery·Andreas PfütznerTimothy S Bailey

Humalog (lispro) for type 2 diabetes

Oct 10, 2012·Expert Opinion on Biological Therapy·Katherine EspositoD Giugliano

Canagliflozin , an inhibitor of sodium-glucose cotransporter 2, for the treatment of type 2 diabetes mellitus

Apr 18, 2013·Expert Opinion on Drug Metabolism & Toxicology·Elizabeth M LamosStephen N Davis

The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus

Aug 15, 2014·Expert Opinion on Drug Discovery·Mikkel ChristensenFilip K Knop

The importance of patient compliance with insulin pens: how can a new user-friendly pen help?

Mar 26, 2014·Expert Opinion on Drug Delivery·Kalliopi Pafili, Nikolaos Papanas

The development of new basal insulins: is there any clinical advantage with their use in type 2 diabetes?

Mar 29, 2014·Expert Opinion on Biological Therapy·Maria Ida MaiorinoKatherine Esposito

Insulin degludec/liraglutide: innovation-driven combination for advancement in diabetes therapy

Apr 8, 2014·Expert Opinion on Biological Therapy·Ajay Kumar

Emerging gliptins for type 2 diabetes

Jun 4, 2013·Expert Opinion on Emerging Drugs·Avivit Cahn, Itamar Raz

Linagliptin for the treatment of type 2 diabetes mellitus: a drug safety evaluation

Oct 30, 2014·Expert Opinion on Drug Safety·Anthony H Barnett

Why are anti-obesity drugs stigmatized?

Dec 23, 2014·Expert Opinion on Drug Safety·Bruno Halpern, Alfredo Halpern

An observational study of glycemic control in canagliflozin treated patients

May 20, 2015·Current Medical Research and Opinion·L M MeckleyRobert A Bailey

Efficacy and safety of the adjustable gastric band - pooled interim analysis of the APEX and HERO studies at 48 weeks

Dec 18, 2013·Current Medical Research and Opinion·Jaime PonceTed Okerson

Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy

Jun 6, 2013·Current Medical Research and Opinion·Keith L DavisWenhui Wei

Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany

Dec 18, 2013·Current Medical Research and Opinion·R GökeM Dworak

Saxagliptin versus glipizide as add-on therapy to metformin: assessment of hypoglycemia

Jan 9, 2014·Current Medical Research and Opinion·Matthew L Mintz, Gianmaria Minervini

Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, placebo-controlled, phase II study

Mar 7, 2014·Current Medical Research and Opinion·Yutaka SeinoYoshishige Samukawa

Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration

Mar 14, 2014·Current Medical Research and Opinion·John B BuseMatthew Wintle

Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study

May 11, 2013·Current Medical Research and Opinion·A OguzH Schmitt

Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial

May 16, 2013·Current Medical Research and Opinion·Zhengpei ZengHans-Juergen Woerle

The value of short- and long-acting glucagon-like peptide-1 agonists in the management of type 2 diabetes mellitus: experience with exenatide

Oct 7, 2015·Current Medical Research and Opinion·Xiao-Hui Guo

Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: a systematic review of the literature from 2008 to 2013

Oct 17, 2015·Current Medical Research and Opinion·M CharokopouBg Verheggen

A comparison of all-cause mortality with pioglitazone and insulin in type 2 diabetes: an expanded analysis from a retrospective cohort study

Jul 2, 2014·Current Medical Research and Opinion·Jiao YangShawn Yu

Ethnic differences in psychological outcomes among people with diabetes: USA results from the second Diabetes Attitudes, Wishes, and Needs (DAWN2) study

Aug 1, 2014·Current Medical Research and Opinion·Mark PeyrotHeather L Stuckey

A practice-based approach to the 2012 position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Apr 26, 2013·Current Medical Research and Opinion·Stanley S Schwartz

Efficacy and safety of linagliptin 2.5 mg twice daily versus 5 mg once daily in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, placebo-controlled trial

Jul 24, 2012·Current Medical Research and Opinion·Stuart A RossHans-Juergen Woerle

Hypoglycemia, its implications in clinical practice, and possible ways to prevent it

Feb 1, 2014·Current Medical Research and Opinion·Pamela Maffioli, Giuseppe Derosa

Association of obesity with glucose, blood pressure, and lipid goals attainment in patients with concomitant diabetes and hypertension

Jun 9, 2015·Current Medical Research and Opinion·Ping LiDYSIS-China Study Investigators

Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting

Oct 31, 2014·Current Medical Research and Opinion·Erin K BuysmanMarcia F T Rupnow

Comparative effectiveness of vildagliptin in combination with other oral anti-diabetes agents in usual-care conditions: the EDGE-Latin America study

May 29, 2014·Current Medical Research and Opinion·Carlos O MendivilOfelia Szyskowsky

Historical cohort analysis of treatment patterns for patients with type 2 diabetes initiating metformin monotherapy

Jul 11, 2015·Current Medical Research and Opinion·Leslie Hazel-FernandezJonathan Bouchard

Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

Jul 28, 2013·Current Medical Research and Opinion·Beth D MitchellMaureen J Lage

A discrete-choice experiment to quantify patient preferences for frequency of glucagon-like peptide-1 receptor agonist injections in the treatment of type 2 diabetes

Nov 10, 2015·Current Medical Research and Opinion·A Brett HauberJames Ruggles

Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey--GALATA study

Feb 24, 2015·Current Medical Research and Opinion·Goksun AyvazGALATA Study Group

Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy

Feb 25, 2015·Current Medical Research and Opinion·Aude Roborel de ClimensKimberly G Brodovicz

Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study

Oct 1, 2013·Current Medical Research and Opinion·Kaj StenlöfGary Meininger

Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study

Apr 9, 2014·Current Medical Research and Opinion·Yutaka SeinoYoshishige Samukawa

Insulin plus incretin agent combination therapy in type 2 diabetes: a systematic review

Oct 11, 2013·Current Medical Research and Opinion·Ronald M Goldenberg

Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study

Mar 29, 2014·Current Medical Research and Opinion·Yutaka SeinoYoshishige Samukawa

Identification of predictors of response to basal insulin and DPP4 inhibitors in patients with type 2 diabetes failing to other therapies

Mar 26, 2015·Acta Diabetologica·Matteo MonamiEdoardo Mannucci

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT

Feb 6, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Timothy S BaileyAmerican College of Endocrinology (ACE)

Long-Acting Phospholipid Gel of Exenatide for Long-Term Therapy of Type II Diabetes

Feb 10, 2016·Pharmaceutical Research·Mei HuYao Fu

Impaired glucose metabolism treatment and carcinogenesis

Dec 2, 2015·Oncology Letters·Artur MatyszewskiCezary Szczylik

Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis

Feb 21, 2016·Cardiovascular Diabetology·Christian SonessonIngrid Gause-Nilsson

Prevalence of comorbidity in primary care patients with type 2 diabetes and its association with elevated HbA1c: A cross-sectional study in Croatia

Feb 9, 2016·Scandinavian Journal of Primary Health Care·Valerija Bralić Lang, Biserka Bergman Marković

GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN

Oct 21, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Beth D MitchellJulie A Settles

Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin

Oct 30, 2014·Diabetes Care·Julio RosenstockNayyar Iqbal

Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: a 24-week randomized, double-blind clinical trial

Jan 17, 2015·Diabetes Care·Stephan MatthaeiStudy 05 Group

Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes

Jan 31, 2015·Diabetes Care·Andrew LewinUli C Broedl

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study

Jul 15, 2015·Diabetes Care·Jay S SkylerMSB-DM003 Investigators

Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum

Oct 1, 2015·Diabetes Care·William T CefaluDonna H Ryan

Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes

Feb 26, 2015·Diabetes·Christopher J NolanMarc Prentki

Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial

Mar 12, 2015·Diabetes Care·Lawrence A LeiterSAVOR-TIMI 53 Steering Committee and Investigators

Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study

Apr 9, 2015·Diabetes Care·Christina M ParrinelloElizabeth Selvin

Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin

Jan 15, 2015·Diabetes Care·Muhammad Abdul-GhaniUli C Broedl

The evolving role of the diabetes educator

Mar 28, 2013·The American Journal of the Medical Sciences·Scott Drab

Achieving glycemic goals with addition of incretin-based therapies to insulin in patients with type 2 diabetes mellitus

Jan 29, 2014·The American Journal of the Medical Sciences·Joseph Tibaldi

Utilization of a Cloud-Based Diabetes Management Program for Insulin Initiation and Titration Enables Collaborative Decision Making Between Healthcare Providers and Patients

Dec 10, 2015·Diabetes Technology & Therapeutics·William C HsuJohn Moore

The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors

Jan 30, 2016·Postgraduate Medicine·Matthew R Weir

Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus

Jan 29, 2016·Drugs·Hannah A Blair, Gillian M Keating

Diabetes Management and Education in Older Adults: The Development of a National Consensus of Key Research Priorities

Dec 1, 2015·Canadian Journal of Diabetes·D Sherifali, Graydon Meneilly

Circadian blood pressure rhythm as a possible key target of SGLT2 inhibitors used for the treatment of Type 2 diabetes

Jan 29, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kouichi TamuraSatoshi Umemura

Role of subcutaneous insulin management protocols and order sets in inpatient diabetes management

Apr 3, 2014·Canadian Journal of Diabetes·Robyn L HouldenKimindra Tiwana

Pragmatic diabetes management in nursing homes: individual care plan

Oct 12, 2013·Journal of the American Medical Directors Association·Athanase BenetosGeorges Weryha

Use of Add-on Treatment to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A U.S. Database Study

Mar 24, 2016·Journal of Managed Care & Specialty Pharmacy·Shengsheng YuKaan Tunceli

Metformin associated lactic acidosis (MALA): clinical profiling and management

Jan 24, 2016·Journal of Nephrology·Alessandra MoioliPaolo Menè

SGLT2 inhibitors for diabetes: turning symptoms into therapy

Jul 16, 2013·Lancet·Michaela Diamant, Linde M Morsink

Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Aug 19, 2015·Endocrine·D GiuglianoKatherine Esposito

Thiazolidinediones/insulin use and cancer risk: insights from the recent meta-analyses

Feb 14, 2013·Diabetes & Metabolism·D Simon

Critical care diabetes education: who, what, when, where, and why

Feb 16, 2013·Critical Care Nursing Clinics of North America·Judy Keaveny

Response: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)

Feb 26, 2016·Diabetes & Metabolism Journal·Jae Seung Yun, Yu Bae Ahn

Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes

Feb 11, 2016·Current Opinion in Endocrinology, Diabetes, and Obesity·Renato QuispeSteven R Jones

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly

Jan 1, 2016·Journal of Endocrinological Investigation·M G BaroniA Avogaro

Designing of the fixed-dose gastroretentive bilayer tablet for sustained release of metformin and immediate release of atorvastatin

Oct 16, 2015·Drug Development and Industrial Pharmacy·Ju-Hee OhYoung-Joo Lee

Does self-efficacy mediate the cross-sectional relationship between perceived quality of health care and self-management of diabetes? Results from Diabetes MILES - Australia

Dec 10, 2015·Psychology & Health·Hannah TregeaJane Speight

Metformin and other antidiabetic agents in renal failure patients

Mar 7, 2014·Kidney International·Jean-Daniel LalauMarc E De Broe

Clinical decisions. Glycemic management in a patient with type 2 diabetes

Oct 4, 2013·The New England Journal of Medicine·Irl B Hirsch, Mark E Molitch

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?

Feb 18, 2016·Journal of Diabetes Research·Irene Ruiz-TamayoXavier Mundet-Tudurí

Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody Response

May 15, 2015·Journal of Medicinal Chemistry·Michael D HambuchenS Michael Owens

Changes of blood fatty acid in women with obesity and type 2 diabetes mellitus

Dec 31, 2015·Biomedit︠s︡inskai︠a︡ khimii︠a︡·N P MikaelyanS A Novikova

A candidate-gene association study of topiramate-induced weight loss in obese patients with and without type 2 diabetes mellitus

Nov 3, 2015·Pharmacogenetics and Genomics·Qingqin S LiStephan Francke

Early Clinical Detection of Pharmacologic Response in Insulin Action in a Nondiabetic Insulin-Resistant Population

Nov 7, 2015·Current Therapeutic Research, Clinical and Experimental·Sudha S ShankarDavid E Kelley

Perceived Barriers and Potential Strategies to Improve Self-Management Among Adults with Type 2 Diabetes: A Community-Engaged Research Approach

Mar 5, 2016·The Patient·Tanjala S PurnellJohn F P Bridges

Fifty-two-week long-term clinical study of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus inadequately controlled with diet and exercise

May 15, 2015·Endocrine Journal·Yutaka SeinoYoshishige Samukawa

Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes

Mar 6, 2015·Endocrine Journal·Kumiko TanakaHiroshi Itoh

Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes

Aug 19, 2015·Internal Medicine·Hitomi NakayamaKentaro Yamada

Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes

Nov 14, 2015·Advances in Therapy·S Lane SlabaughD Chad Moretz

Proportion of Brazilian diabetes patients that achieve treatment goals: implications for better quality of care

Dec 18, 2015·Diabetology & Metabolic Syndrome·Deise Regina BaptistaCassyano Januário Correr

Yoga for Adults with Type 2 Diabetes: A Systematic Review of Controlled Trials

Jan 21, 2016·Journal of Diabetes Research·Kim E Innes, Terry Kit Selfe

Participatory approach to the development of a knowledge base for problem-solving in diabetes self-management

Nov 9, 2015·International Journal of Medical Informatics·Heather J Cole-LewisLena Mamykina

The Importance of Weight Change Experiences for Performance of Diabetes Self-Care: A Patient-Centered Approach to Evaluating Clinical Outcomes in Type 2 Diabetes

Nov 27, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Shana B TrainaWilliam Canovatchel

Characterization of Sitagliptin Use in Patients with Type 2 Diabetes and Chronic Kidney Disease by Cross-Sectional Analysis of a Medical Insurance Claims Database

Oct 7, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Kimberly G BrodoviczSamuel S Engel

Assessing the Associations of Patient-Reported Perceptions of Patient-Centered Care as Supplemental Measures of Health Care Quality in VA

Mar 10, 2016·Journal of General Internal Medicine·Bella EtingenSherri L LaVela

Time dictates: emerging clinical analyses of the impact of circadian rhythms on diagnosis, prognosis and treatment of disease

Dec 5, 2015·Clinical Medicine : Journal of the Royal College of Physicians of London·Andras D Nagy, Akhilesh B Reddy

Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice

Dec 4, 2015·BMC Cardiovascular Disorders·Pâmela Santana DaltroSimone Garcia Macambira

Identifying consumer's needs of health information technology through an innovative participatory design approach among English- and Spanish-speaking urban older adults

Jan 16, 2015·Applied Clinical Informatics·R LuceroV Tiase

Is hypoglycemia fear independently associated with health-related quality of life?

Dec 1, 2014·Health and Quality of Life Outcomes·Lizheng ShiNina A Thomas

Quantitative combination of natural anti-oxidants prevents metabolic syndrome by reducing oxidative stress

Aug 12, 2015·Redox Biology·Mingjing GaoBaolu Zhao

Impact of body weight on antidiabetic treatment and predictors of weight control under real-world conditions: a 2-year follow-up of DiaRegis cohort

Aug 5, 2015·Acta Diabetologica·B HartmannAnselm K Gitt

Keys to long-term care of the liver transplant recipient

Oct 16, 2015·Nature Reviews. Gastroenterology & Hepatology·Kymberly D Watt

Attributing discrimination to weight: associations with well-being, self-care, and disease status in patients with type 2 diabetes mellitus

Jul 3, 2015·Journal of Behavioral Medicine·Lindsey PotterJoshua Smyth

THE SYNERGY TO ENABLE GLYCEMIC CONTROL FOLLOWING EMERGENCY DEPARTMENT DISCHARGE PROGRAM FOR ADULTS WITH TYPE 2 DIABETES: STEP-DIABETES

Jul 28, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Michelle F MageeJeffrey S Dubin

Vitamin B12 deficiency is associated with adverse lipid profile in Europeans and Indians with type 2 diabetes

Oct 7, 2014·Cardiovascular Diabetology·Antonysunil AdaikalakoteswariPonnusamy Saravanan

Insulin initiation: bringing objectivity to choice

Apr 16, 2015·Journal of Diabetes and Metabolic Disorders·Sanjay Kalra, Yashdeep Gupta

Effectiveness and tolerability of second-line therapy with vildagliptin versus other oral agents in type 2 diabetes (EDGE): post-hoc subanalysis of the Belgian data

May 14, 2014·Acta Clinica Belgica·J HosteChantal Mathieu

Is gliclazide a sulfonylurea with difference? A review in 2016

Mar 1, 2016·Expert Review of Clinical Pharmacology·Awadhesh Kumar Singh, Ritu Singh

Response letter to Gazzaruso and colleagues

Apr 16, 2013·Journal of the American Geriatrics Society·Sei J LeeCatherine Eng

A patient-centred approach to treatment with incretin-based agents in patients with type 2 diabetes

Feb 28, 2013·Journal of Clinical Pharmacy and Therapeutics·Susan Cornell

The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes

Aug 21, 2013·Diabetes/metabolism Research and Reviews·Y BiD L Zhu

Changes in weight loss-related quality of life among type 2 diabetes mellitus patients treated with dapagliflozin

Jan 22, 2014·Diabetes, Obesity & Metabolism·S GrandyC D Sjöström

Anorexia nervosa complicated by diabetes mellitus: the case for permissive hyperglycemia

Apr 11, 2014·The International Journal of Eating Disorders·Carrie Brown, Philip S Mehler

Diabetes self-management programmes in older adults: a systematic review and meta-analysis

Apr 14, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·D SherifaliM U Ali

How many people inject insulin? UK estimates from 1991 to 2010

Jan 15, 2014·Diabetes, Obesity & Metabolism·Sarah E HoldenCraig J Currie

Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial

Mar 18, 2016·Diabetologia·David E CummingsDavid R Flum

Dimensions of medication adherence in African Americans with type 2 diabetes in rural North Carolina

Mar 19, 2016·Journal of the American Association of Nurse Practitioners·Stephen BlackmonJeanne Kemppainen

The role of Toujeo®, insulin glargine U-300, in the treatment of diabetes mellitus

Mar 19, 2016·Journal of the American Association of Nurse Practitioners·Meagan A BrownJoshua W Fleming

Hemoglobin A1c in patients on peritoneal dialysis: how should we interpret it?

Feb 28, 2014·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Silvia Coelho, Anabela Rodrigues

Intensification of antihyperglycemic therapy among patients with incident diabetes: a Surveillance Prevention and Management of Diabetes Mellitus (SUPREME-DM) study

Mar 19, 2014·Pharmacoepidemiology and Drug Safety·Marsha A RaebelJohn F Steiner

American Diabetes Association 73rd Scientific Sessions, Chicago, Illinois, USA, 2013

Oct 12, 2013·Journal of Diabetes·Manu V VenkatKelly L Close

Mediterranean diet and type 2 diabetes

Dec 21, 2013·Diabetes/metabolism Research and Reviews·Katherine Esposito, D Giugliano

Premixed insulin regimens in type 2 diabetes: pros

Mar 24, 2016·Endocrine·Maria Ida MaiorinoD Giugliano

Clinical Predictors of Progressive Beta-Cell Failure in Type 2 Diabetes

Jun 10, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Concetta IraceAgostino Gnasso

Thymic emigration patterns in patients with type 2 diabetes treated with metformin

Aug 15, 2015·Immunology·Grzegorz DworackiMarzena Dworacka

Further investigation of the psychometric properties of the Insulin Treatment Appraisal Scale among insulin-using and non-insulin-using adults with type 2 diabetes: results from Diabetes MILES-Australia

Jun 7, 2014·Health and Quality of Life Outcomes·Elizabeth Holmes-TruscottJane Speight

Clinical Assessment of Individualized Glycemic Goals in Patients With Type 2 Diabetes: Formulation of an Algorithm Based on a Survey Among Leading Worldwide Diabetologists

Nov 1, 2015·Diabetes Care·Avivit CahnWilliam T Cefalu

Study of Insulin Requirement Modeling in Hospitalized Elderly Patients with Type 2 Diabetes at a Late Stage of Stepwise Escalation Therapy

Mar 31, 2016·Diabetes Technology & Therapeutics·Afshan Nourizadeh-SedaghatiBrigitte Delemer

Food insecurity, coping strategies and glucose control in low-income patients with diabetes

Sep 4, 2015·Public Health Nutrition·Victoria L MayerJudith A Long

INTRAVENOUS CONTRAST IN PATIENTS WITH DIABETES ON METFORMIN: NEW COMMON SENSE GUIDELINES

Jan 21, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Arti D ShahRobert J Rushakoff

HYPERGLYCEMIA MANAGEMENT IN PATIENTS WITH POSTTRANSPLANTATION DIABETES

Jan 1, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Rodolfo J GalindoRonald Tamler

Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program

Apr 3, 2016·Current Diabetes Reports·Hui PengVanita R Aroda

Health Coaching Reduces HbA1c in Type 2 Diabetic Patients From a Lower-Socioeconomic Status Community: A Randomized Controlled Trial

Oct 7, 2015·Journal of Medical Internet Research·Noah WaynePaul Ritvo

Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label Trial

Apr 19, 2015·Diabetes Care·Juris J MeierChristoph Kapitza

Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics

Jun 7, 2015·Diabetes Care·Margaret A PowersEva Vivian

Dapagliflozin's Effects on Glycemia and Cardiovascular Risk Factors in High-Risk Patients With Type 2 Diabetes: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study With a 28-Week Extension

Apr 9, 2015·Diabetes Care·William T CefaluS Parikh

Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149

Jul 25, 2015·Diabetes Care·Gijs W D LandmanSebastiaan T Houweling

Response to Comments on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149

Jul 25, 2015·Diabetes Care·Silvio E InzucchiManagement of Hyperglycemia in Type 2 Diabetes American Diabetes Association and European Association for the Study of Diabe

The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy

Apr 12, 2014·Diabetes Care·Pascale FouquerayClifford J Bailey

Metformin and cancer: mounting evidence against an association

Jun 26, 2014·Diabetes Care·Samy Suissa, Laurent Azoulay

Patient preferences for noninsulin diabetes medications: a systematic review

Jun 26, 2014·Diabetes Care·Tanjala S PurnellNisa M Maruthur

AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus

Sep 20, 2015·Drugs·Esther S Kim, Greg L Plosker

Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database

Jun 27, 2015·European Heart Journal·G P FadiniOsMed Health-DB Network

Diabetic patients' perspectives on the challenges of glycaemic control

Aug 8, 2015·African Journal of Primary Health Care & Family Medicine·Oladele V AdeniyiBenjamin Longo-Mbenza

Practical Guidance on the Use of Premix Insulin Analogs in Initiating, Intensifying, or Switching Insulin Regimens in Type 2 Diabetes

Jun 25, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ted WuGreg Fulcher

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis

Jul 6, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Haoda FuHaya Ascher-Svanum

Allosteric Optical Control of a Class B G-Protein-Coupled Receptor

Apr 10, 2016·Angewandte Chemie·Johannes BroichhagenDavid J Hodson

Type II diabetes and its therapy in clinical practice - results from the standardised non-interventional registry SIRTA

Oct 10, 2014·International Journal of Clinical Practice·Baptist GallwitzK Fresenius

Geographic patterns in patient demographics and insulin use in 18 countries, a global perspective from the multinational observational study assessing insulin use: understanding the challenges associated with progression of therapy (MOSAIc)

Sep 12, 2015·BMC Endocrine Disorders·Jennifer M PolinskiBradley H Curtis

Efficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literature

May 18, 2016·Indian Journal of Endocrinology and Metabolism·Ajay Kumar

Prevalence, Clinical Correlates, and Use of Glucose-Lowering Drugs among Older Patients with Type 2 Diabetes Living in Long-Term Care Facilities

Oct 2, 2015·Journal of Diabetes Research·Mario BoNicoletta Aimonino Ricauda

Insulin Degludec/Liraglutide: A Review in Type 2 Diabetes

Aug 6, 2015·Drugs·Sarah L Greig, Lesley J Scott

Effects of dose escalating liraglutide from 1.2 to 1.8 mg in clinical practice: a case-control study

Sep 4, 2015·Journal of Endocrinological Investigation·M RigatoG P Fadini

Pharmacogenetics and individual responses to treatment of hyperglycemia in type 2 diabetes

Jul 17, 2015·Pharmacogenetics and Genomics·Line EngelbrechtsenHenrik Vestergaard

Increased circulating betatrophin concentrations in patients with type 2 diabetes

Jun 26, 2014·International Journal of Endocrinology·Daniel EspesPer-Ola Carlsson

Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149

Aug 22, 2015·Diabetes Care·James P McCormackDavid H Newman

Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

Aug 8, 2015·Diabetes Care·Caroline S FoxAmerican Diabetes Association

Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement

Oct 2, 2015·Indian Journal of Endocrinology and Metabolism·Sanjay KalraUditha Bulughapitiya

User Assessment of "InsuOnLine," a Game to Fight Clinical Inertia in Diabetes: A Pilot Study

Aug 20, 2015·Games for Health Journal·Leandro A DiehlIzabel C M M Coelho

Food protein-derived bioactive peptides in management of type 2 diabetes

Jul 11, 2015·European Journal of Nutrition·Prasad PatilSantosh Anand

Results of the Adequacy of glycemiC Control in pAtients with type 2 Diabetes mEllitus treated with Metformin monotherapY at the maximal-tolerated dose (ACCADEMY) study

Aug 16, 2015·Endocrine·Carlo B GiordaACCADEMY Study Group

TWO TREATMENT APPROACHES FOR HUMAN REGULAR U-500 INSULIN IN PATIENTS WITH TYPE 2 DIABETES NOT ACHIEVING ADEQUATE GLYCEMIC CONTROL ON HIGH-DOSE U-100 INSULIN THERAPY WITH OR WITHOUT ORAL AGENTS: A RANDOMIZED, TITRATION-TO-TARGET CLINICAL TRIAL

Mar 31, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Robert C HoodJeffrey A Jackson

Acalculous pyelonephritis and cholecystitis occurring simultaneously in a diabetic patient on sitagliptin therapy

Aug 28, 2015·Journal of Pharmacology & Pharmacotherapeutics·Jayaprakash SahooRathinam Palamalai Swaminathan

Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers

Dec 31, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Lin-Zhi ChenSreeraj Macha

Novel Therapeutics for Diabetes: Uptake, Usage Trends, and Comparative Effectiveness

Apr 15, 2016·Current Diabetes Reports·Vishal Ahuja, Chia-Hung Chou

Guidelines in the management of the diabetes mellitus type 2

Jan 18, 2015·Semergen·M Seguí DíazJ A Divisón

The Genetic Profile from HLA and Non-HLA Loci Allows Identification of Atypical Type 2 Diabetes Patients

Aug 15, 2015·Journal of Diabetes Research·Matias FabregatAdriana Mimbacas

Emerging treatments for post-transplantation diabetes mellitus

Apr 29, 2015·Nature Reviews. Nephrology·Trond Jenssen, Anders Hartmann

Type 2 diabetes mellitus

Jan 1, 2015·Nature Reviews. Disease Primers·Muhammad Abdul-GhaniRam Weiss

Glycemic Variability: Assessing Glycemia Differently and the Implications for Dietary Management of Diabetes

May 15, 2015·Annual Review of Nutrition·Jeannie TayGrant D Brinkworth

Similarities and differences between patients included and excluded from a randomized clinical trial of vitamin D supplementation for improving glucose tolerance in prediabetes: interpreting broader applicability

Jul 16, 2015·Trials·Yuval EisenbergElena Barengolts

Sleep apnea syndrome in endocrine clinics

Jul 1, 2015·Journal of Endocrinological Investigation·F CeccatoC Scaroni

Unintended positive and negative effects of drugs on lipoproteins

Jun 24, 2015·Current Opinion in Lipidology·Tarza J SiahmansurHandrean Soran

Efficacy and safety of dulaglutide added onto pioglitazone and metformin versus exenatide in type 2 diabetes in a randomized controlled trial (AWARD-1)

Jun 1, 2014·Diabetes Care·Carol WyshamMark Lakshmanan

HARMONY 3: 104-week randomized, double-blind, placebo- and active-controlled trial assessing the efficacy and safety of albiglutide compared with placebo, sitagliptin, and glimepiride in patients with type 2 diabetes taking metformin

Jun 6, 2014·Diabetes Care·Bo AhrénHARMONY 3 Study Group

Factors associated with weight gain in people with type 2 diabetes starting on insulin

May 16, 2014·Diabetes Care·Beverley BalkauNick Freemantle

Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3)

May 21, 2014·Diabetes Care·Guillermo E UmpierrezValeria Pechtner

Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: a randomized, double-blind, phase 3 study

Sep 11, 2014·Diabetes Care·Lawrence A LeiterGary Meininger

The association between different A1C-based measures of glycemia and risk of cardiovascular disease hospitalization

Aug 31, 2013·Diabetes Care·Gregory A NicholsStephen P Fortmann

Cardiovascular events and geriatric scale scores in elderly (70 years old and above) type 2 diabetic patients at inclusion in the GERODIAB cohort

Aug 31, 2013·Diabetes Care·Bernard BauduceauSFD/SFGG Intergroup and the GERODIAB Group

A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine

Mar 31, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Chantal MathieuSamuel S Engel

Efficacy and safety of canagliflozin, an inhibitor of sodium-glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes

Dec 4, 2014·Diabetes Care·Bruce NealCANVAS Trial Collaborative Group

Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)

Apr 20, 2014·Diabetes Care·Michael A NauckZvonko Milicevic

Response to comment on Khunti et al. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes care 2013;36:3411-3417

Apr 24, 2014·Diabetes Care·Kamlesh KhuntiM J Davies

Use of antidiabetic drugs in the U.S., 2003-2012

Mar 14, 2014·Diabetes Care·Christian HamppDiane K Wysowski

Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement

Dec 21, 2013·Diabetes Care·Mayer B Davidson

Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial

May 9, 2014·Diabetes Care·Gregory FulcherLeo K Niskanen

Injectable Coformulations in Diabetology

Mar 25, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay Kalra, Yashdeep Gupta

The effect of anaemia and abnormalities of erythrocyte indices on HbA1c analysis: a systematic review

May 23, 2015·Diabetologia·Emma EnglishW Garry John

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

Jan 31, 2015·Cardiovascular Diabetology·Rimei NishimuraUli C Broedl

Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study

Jan 24, 2015·Critical Care : the Official Journal of the Critical Care Forum·Palash KarAdam M Deane

Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges

Jun 3, 2015·Current Cardiology Reports·M Odette GoreJulio Rosenstock

Clinical Outcomes of Continuation of Metformin Titration Instructions with Electronic Prescribing

Jun 1, 2015·Drugs -- Real World Outcomes·Thomas DelateSheryl J Herner

Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy

Jan 30, 2015·Clinical Therapeutics·Annunziata LapollaNatalino Simioni

Sulfonylureas in today's blood glucose lowering therapy. New data on advantages and potential barriers of an "old" antidiabetic group

Mar 23, 2015·Orvosi hetilap·Gábor Winkler

Self-report of hypoglycemia and health-related quality of life in patients with type 1 and type 2 diabetes

Jun 13, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Rozalina G McCoySteven Smith

Assessment of AACE/ACE recommendations for initial dual antihyperglycemic therapy using the fixed-dose combination of sitagliptin and metformin versus metformin

Jun 13, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Samuel S EngelBarry J Goldstein

Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes: A 6-month, Randomized, Double-blind, Placebo-controlled Study

Dec 12, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·James ThrasherHans-Juergen Woerle

Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare)

Feb 13, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Bruce W BodeHelena W Rodbard

Reshaping diabetes care: the fundamental role of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 receptor agonists in clinical practice

Mar 21, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Guillermo E Umpierrez, Luigi Meneghini

Effect of baseline glycosylated hemoglobin A1c on glycemic control and diabetes management following initiation of once-daily insulin detemir in real-life clinical practice

Jan 23, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Salvatore CaputoSOLVE Study Group

Alogliptin

Jan 15, 2014·Hospital Pharmacy·Dennis J CadaDanial E Baker

Current issues in GLP-1 receptor agonist therapy for type 2 diabetes

Jan 15, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Zachary T BloomgardenCarol Wysham

Hemoglobin A1C, mean glucose, and persistence of glycation ratios in insulin-treated diabetes

Nov 20, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Nicholas B ArgentoPeter Simpson

Hypoglycemia: minimizing its impact in type 2 diabetes

Feb 22, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Etie S MoghissiRobin Cammarota Devine

Adding Rapid-Acting Insulin or GLP-1 Receptor Agonist to Basal Insulin: Outcomes in a Community Setting

Aug 26, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Mehul R DalalAndres DiGenio

Patient-led versus physician-led titration of insulin glargine in patients with uncontrolled type 2 diabetes: a randomized multinational atlas study

Oct 10, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Satish K GargRiccardo Perfetti

Liraglutide achieves A1C targets more often than sitagliptin or exenatide when added to metformin in patients with type 2 diabetes and a baseline A1C <8.0%

Nov 29, 2012·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Allen B KingGiorgio Sesti

The right tool for the job

Jun 18, 2014·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Matthew C Leinung

The placement of DPP-4 inhibitors in clinical practice recommendations for the treatment of type 2 diabetes

Oct 16, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Jaime A Davidson

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary

Jul 3, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Alan J GarberMichael H Davidson

Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males

May 16, 2015·Advances in Therapy·Takashi SasakiYoshishige Samukawa

Why screening for type 2 diabetes is necessary even in poor resource settings

Jun 24, 2015·Journal of Diabetes and Its Complications·Ranjit Unnikrishnan, Viswanathan Mohan

β cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians

May 7, 2015·Current Diabetes Reports·Daisuke YabeSusumu Seino

Is there any progress in the blood glucose lowering therapy of type 2 diabetes?

Aug 6, 2014·Orvosi hetilap·Gábor Winkler

Efficacy and tolerability of vildagliptin-based versus comparative dual therapy in type 2 diabetes : Results of the Austrian subpopulation of the EDGE study

Jan 13, 2015·Wiener klinische Wochenschrift·Helmut BrathMichaela Ratzinger

The pace of change in medical practice and health policy: collision or coexistence?

Jan 23, 2015·Journal of General Internal Medicine·Neda Laiteerapong, Elbert S Huang

The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics

Mar 17, 2015·Cancer Causes & Control : CCC·Ilir AgalliuReza Ghavamian

Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study

Jun 20, 2015·International Journal of Endocrinology·Grigorios RombopoulosMoyses Elisaf

Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry

May 3, 2015·BMC Endocrine Disorders·Roland E SchmiederDIALOGUE study group

Mechanisms of Cardiovascular Injury in Type 2 Diabetes and Potential Effects of Dipeptidyl Peptidase-4 Inhibition

Apr 2, 2015·The Journal of Cardiovascular Nursing·Betsy Dokken

Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations

Jun 22, 2014·Pituitary·Laura TrementinoGiorgio Arnaldi

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)

May 6, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Guideline development group

Alogliptin: a review of its use in patients with type 2 diabetes mellitus

Apr 10, 2015·Drugs·Gillian M Keating

Effects of canagliflozin on body weight and relationship to HbA1c and blood pressure changes in patients with type 2 diabetes

Mar 31, 2015·Diabetologia·William T CefaluGary Meininger

Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study

Apr 3, 2015·Advances in Therapy·Erin K BuysmanJakob Langer

Efficacy and safety of empagliflozin monotherapy for 52 weeks in Japanese patients with type 2 diabetes: a randomized, double-blind, parallel-group study

Apr 8, 2015·Advances in Therapy·Takashi KadowakiUli C Broedl

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Apr 15, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Yehuda HandelsmanFarhad Zangeneh

Clinical utility of insulin and insulin analogs

Apr 16, 2013·Islets·Ahter D SanliogluSalih Sanlioglu

Euglycemia in Diabetic Rats Leads to Reduced Liver Weight via Increased Autophagy and Apoptosis through Increased AMPK and Caspase-3 and Decreased mTOR Activities

Jun 11, 2015·Journal of Diabetes Research·Jun-Ho LeeYun-Hee Noh

Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study

Dec 17, 2014·Diabetes·Tanja DujicEwan R Pearson

Intensive individualized reinforcement education is important for the prevention of hypoglycemia in patients with type 2 diabetes

Apr 30, 2015·Diabetes & Metabolism Journal·Yun-Mi YongYu-Bae Ahn

Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity

Jun 8, 2013·Bioorganic & Medicinal Chemistry Letters·Martin LorenzMichael Wagner

Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs

Apr 19, 2015·BMC Pharmacology & Toxicology·M Elle SaineVincent Lo Re